NCT06850454View on ClinicalTrials.gov

Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy

PHASE3RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

January 10, 2026

Study Completion Date

January 31, 2026

Conditions
Chemotherapy Induced Nausea and Vomiting
Interventions
DRUG

olanzapine

olanzapine 5 mg oral prior to chemotherapy on day 1 and daily on day 2-4

DRUG

Placebo

placebo 5 mg oral prior to chemotherapy on day 1 and daily on day 2-4

Trial Locations (1)

10700

RECRUITING

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER